提摩尔作为一种潜在的天然抗发药:来自体内和体内研究的见解
Showkoth Akbor1, Mehedi Hasan Bappi1, Abdullah Al Shamsh Prottay1
1Department of Pharmacy Gopalganj Science and Technology University Gopalganj Bangladesh.
Food science & nutrition
|September 12, 2025
概括
提摩尔 (THY) 是一种天然化合物,在模型中有效降低了恶心和吐. 它的多目标受体结合和有利的安全性概况表明它有可能作为一种广泛的抗药剂.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
- 计算化学的计算化学
背景情况:
- 恶心和吐是常见的,令人痛苦的症状需要有效和安全的治疗.
- 当前的抗药物可能会产生不良影响,需要寻找更安全的替代品.
- 乙醇 (THY),一种来自精油的单烯,呈现出一种潜在的天然治疗剂.
研究的目的:
- 评估使用体内和的方法提摩尔 (THY) 的抗性潜力.
- 为了研究单独的THY和与标准抗药物结合的疗效.
- 评估THY与其抗作用相关的分子相互作用和药理动力学特性.
主要方法:
- 在2天大的小中进行体内抗emetic测定,诱导与硫酸铜五水合物.
- 口服THY的剂量不同 (10,20,40毫克/公斤),并与标准的抗emetics结合使用.
- 在的分子对接和吸收,分布,新陈代谢,分泌和毒性 (ADMET) 分析.
主要成果:
- 20毫克/千克的THY剂量显著减少了67.2%的口,并增加了77.18%的第一个口的延迟时间.
- 与THY和Ondansetron的联合治疗显示出增强的抗效应.
- 分子对接揭示了THY与关键抗emetic受体 (5-HT3A,D2,M3,H1) 的强烈结合亲和力.
- 亚德梅特 (ADMET) 分析表明THY具有有利的药理动力学特性和低毒性风险.
结论:
- 蒂摩尔通过多目标结合机制显示出显著的抗效果.
- THY表现出有前途的安全性和药理动力学特征,表明其作为天然抗药的潜力.
- 需要进一步的研究,包括受体特异性研究和临床试验,以确认THY的治疗价值.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
817
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
817
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
606
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
606
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
676
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
676
Cholinergic Antagonists: Pharmacokinetics
908
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
908
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
597
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
597
Cholinergic Antagonists: Pharmacological Actions
1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K


